- Home
- VCEL vs ROOT Comparison
VCEL vs ROOT Comparison
Compare VCEL & ROOT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VCEL
- ROOT
- Stock Information
- Founded
- VCEL 1989
- ROOT 2015
- Country
- VCEL United States
- ROOT United States
- Employees
- VCEL N/A
- ROOT N/A
- Industry
- VCEL Biotechnology: Biological Products (No Diagnostic Substances)
- ROOT Property-Casualty Insurers
- Sector
- VCEL Health Care
- ROOT Finance
- Exchange
- VCEL Nasdaq
- ROOT Nasdaq
- Market Cap
- VCEL 2.1B
- ROOT 2.3B
- IPO Year
- VCEL 1997
- ROOT 2020
- Fundamental
- Price
- VCEL $34.05
- ROOT $92.64
- Analyst Decision
- VCEL Strong Buy
- ROOT Buy
- Analyst Count
- VCEL 6
- ROOT 6
- Target Price
- VCEL $61.50
- ROOT $130.60
- AVG Volume (30 Days)
- VCEL 565.9K
- ROOT 569.5K
- Earning Date
- VCEL 07-31-2025
- ROOT 10-29-2025
- Dividend Yield
- VCEL N/A
- ROOT N/A
- EPS Growth
- VCEL 2045.40
- ROOT N/A
- EPS
- VCEL 0.13
- ROOT 4.73
- Revenue
- VCEL $249,119,000.00
- ROOT $1,364,700,000.00
- Revenue This Year
- VCEL $18.35
- ROOT $27.16
- Revenue Next Year
- VCEL $22.47
- ROOT $9.22
- P/E Ratio
- VCEL $256.98
- ROOT $19.59
- Revenue Growth
- VCEL 16.13
- ROOT 59.76
- 52 Week Low
- VCEL $33.09
- ROOT $34.04
- 52 Week High
- VCEL $63.00
- ROOT $181.14
- Technical
- Relative Strength Index (RSI)
- VCEL 40.14
- ROOT 44.15
- Support Level
- VCEL $33.34
- ROOT $87.46
- Resistance Level
- VCEL $36.81
- ROOT $94.89
- Average True Range (ATR)
- VCEL 1.36
- ROOT 4.27
- MACD
- VCEL -0.13
- ROOT 1.69
- Stochastic Oscillator
- VCEL 20.14
- ROOT 79.77
About VCEL Vericel Corporation
Vericel Corp is a fully integrated, commercial-stage biopharmaceutical company and a provider of therapies for the sports medicine and severe burn care markets. It markets cell therapy products in the United States, MACI (autologous cultured chondrocytes on porcine collagen membrane); Epicel (cultured epidermal autografts); and NexoBrid. The Company operates its business in the U.S. in one reportable segment; the research, product development, manufacture, and distribution of cellular therapies and specialty biologics for use in the treatment of specific conditions.
About ROOT Root Inc.
Root Inc develops and launches a direct-to-consumer personal automobile insurance and mobile technology company. It generates revenue from the sales of auto insurance policies within the United States.